These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2239603)

  • 1. [Clinical study of iohexol in excretory urography].
    Nagai T; Okamura K; Yokoi K; Ando T; Sahashi M; Miyake K; Kobayashi H; Obata K; Fukatsu H; Segawa A
    Hinyokika Kiyo; 1990 Aug; 36(8):963-7. PubMed ID: 2239603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelography with Omnipaque (Iohexol) using basic radiographic facilities: the main adverse effects.
    Ndosi BN; Ndosi NK; Kazema RR
    Cent Afr J Med; 1996 Jul; 42(7):192-5. PubMed ID: 8936782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iohexol and ioxithalamate for intravenous urography. A comparative parallel study.
    Egeblad M; Nielsen NT; Fries J; Laulund S
    Eur J Radiol; 1985 Aug; 5(3):240-2. PubMed ID: 3896801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonionic versus ionic contrast media in intravenous urography: clinical trial in 1,000 consecutive patients.
    Jacobsson BF; Jorulf H; Kalantar MS; Narasimham DL
    Radiology; 1988 Jun; 167(3):601-5. PubMed ID: 3283830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelography using iohexol (Omnipaque).
    Peeters F
    Diagn Imaging Clin Med; 1986; 55(6):348-51. PubMed ID: 3643831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravascular studies with iohexol (Omnipaque). Results from the first 49 clinical trials.
    Andrew E; Dahlstrøm K; Sveen K; Hvinden G; Holager T; Mowinckel P; Renaa T; Laulund S
    Eur J Radiol; 1985 Feb; 5(1):68-76. PubMed ID: 3891345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quality control in urography with iopamidol and iohexol. A parallel comparison].
    Stacul F; Bazzocchi M; Zanella F; Abbona M; Ukovich W
    Radiol Med; 1987 Mar; 73(3):196-8. PubMed ID: 3562919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The optimum dose of iohexol 399 in excretory urography].
    Ohshima S; Matsuura O; Takeuchi N; Hattori R; Hashimoto J; Segawa A
    Hinyokika Kiyo; 1989 Aug; 35(8):1457-62. PubMed ID: 2683658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous digital subtraction angiography with iohexol (Omnipaque) and sodium meglumin diatrizoate (Urografin).
    Karle A; Fries J; Laulund S; Andrew E
    Diagn Imaging Clin Med; 1986; 55(6):352-9. PubMed ID: 3545629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonionic contrast media in pediatric CT. A comparative study of intravenous use of iopentol and iohexol.
    Wiklund LM; Brolin I; Sjöholm K
    Acta Radiol; 1994 Mar; 35(2):186-90. PubMed ID: 8172749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Excretory urography: comparison of the ionic contrast medium amidotrezoic acid with the non-ionic contrast medium iohexol].
    Grabenwöger F; Dock W; Pinterits F; Metz V
    Wien Med Wochenschr; 1989 Feb; 139(3):48-50. PubMed ID: 2650470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The adverse effects of the water-soluble iodinated contrast media used in excretory urography in the canine species].
    Hita Rosino E; Agut Giménez A; Sánchez-Valverde García MA
    Actas Urol Esp; 1999 May; 23(5):385-93. PubMed ID: 10427811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iohexol in excretory urography. Results of drug monitoring].
    Schrott KM; Behrends B; Clauss W; Kaufmann J; Lehnert J
    Fortschr Med; 1986 Feb; 104(7):153-6. PubMed ID: 3516817
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II studies in urography, cardioangiography and cerebral angiography with iohexol. An evaluation of the clinical trial program and the clinical findings.
    Andrew E; Sveen K; Renaa T; Dahlstrøm K
    Eur J Radiol; 1983 Aug; 3(3):194-201. PubMed ID: 6628397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Examination by densitometer on visualization of non-ionic contrast medium (iohexol) in excretory urography. 1. Visualization by bolus injection].
    Ikeuchi T; Hamashima T; Sakamoto M
    Hinyokika Kiyo; 1990 Feb; 36(2):131-6. PubMed ID: 2343806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences with iohexol (Omnipaque) at urography.
    Fjelldal A; Nordshus T; Eriksson J
    Pediatr Radiol; 1987; 17(6):491-2. PubMed ID: 3684363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excretory urography with iohexol: evaluation in children.
    Magill HL; Clarke EA; Fitch SJ; Boulden TF; Ramirez R; Siegle RL; Somes GW
    Radiology; 1986 Dec; 161(3):625-30. PubMed ID: 3786708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodixanol in paediatric excretory urography: efficiency and safety compared to iohexol.
    Dacher J; Sirinelli D; Boscq M; Hassan M; Garel C; Chateil JF; Amar C
    Pediatr Radiol; 1998 Feb; 28(2):112-4. PubMed ID: 9472058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iohexol and ioxaglate in peripheral angiography.
    Stiris MG; Laerum F
    Acta Radiol; 1987; 28(6):767-70. PubMed ID: 2962617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved visualization of the urinary tract in multidetector CT urography (MDCTU): analysis of individual acquisition delay and opacification using furosemide and low-dose test images.
    Kemper J; Regier M; Stork A; Adam G; Nolte-Ernsting C
    J Comput Assist Tomogr; 2006; 30(5):751-7. PubMed ID: 16954923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.